Literature DB >> 563706

Cutaneous mycosis caused by Paecilomyces lilacinus.

S Takayasu, M Akagi, Y Shimizu.   

Abstract

A 20-year-old woman had erythematous scaly plaques persistent for 15 years on the left cheek. Cultures from scales and biopsy specimens on Sabouraud's glucose agar repeatedly yielded floccose lilac colonies, and those on a Czapek's solution agar plate developed deep purplish red pigment, which is characteristic of Paecilomyces lilacinus. The PAS stain of the tissue section showed ovoid, divergent, or club-shaped fungal elements among the inflammatory cells or in giant cells. Two months after the patient and a control subject were inoculated with the isolates, P lilacinus could be reisolated from the patient only. Oral administration of griseofulvin significantly reduced erythema and papules. This is the first report, to our knowledge, of deep cutaneous mycosis caused by P lilacinus.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 563706

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  5 in total

1.  Hyalohyphomycosis caused by Paecilomyces variotii: a case report, animal pathogenicity and 'in vitro' sensitivity.

Authors:  J Naidu; S M Singh
Journal:  Antonie Van Leeuwenhoek       Date:  1992-10       Impact factor: 2.271

2.  Paecilomyces lilacinus as the cause of chronic maxillary sinusitis.

Authors:  R C Rockhill; M D Klein
Journal:  J Clin Microbiol       Date:  1980-06       Impact factor: 5.948

3.  Paecilomyces lilacinus catheter-related fungemia in an immunocompromised pediatric patient.

Authors:  T Q Tan; A K Ogden; J Tillman; G J Demmler; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

Review 4.  Complicated soft tissue infection with prepatellar bursitis caused by Paecilomyces lilacinus in an immunocompetent host: case report and review.

Authors:  F Westenfeld; W K Alston; W C Winn
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

Review 5.  Paecilomyces lilacinus vaginitis in an immuno-competent patient.

Authors:  Jeanne Carey; Ron D'Amico; Deanna A Sutton; Michael G Rinaldi
Journal:  Emerg Infect Dis       Date:  2003-09       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.